Stock Comparison
MDLN vs SOLV
Medline Inc. Class A Common Stock and Solventum Corp. side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$69.26B
$13.77B
P/E (TTM)
34.1
9.7
Forward P/E
26.3
12.1
Price/Sales
2.4
1.7
Price/Book
2.9
2.8
EV/EBITDA
14.6
7.4
Dividend Yield
—
—
Profitability
Net Margin
3.32%
17.30%
Operating Margin
5.43%
5.58%
Return on Equity
6.05%
34.80%
Return on Assets
3.66%
2.75%
Growth (YoY)
Revenue Growth
10.70%
-3.00%
Earnings Growth
1258.00%
-91.00%
Price & Risk
Beta
—
0.7
52-Week High
$50.88
$88.20
52-Week Low
$32.81
$62.38
Analyst Target
$51.15
$82.15
Compare MDLN and SOLV your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.